Our Solutions   by Brands   MinoStrong-F   Fosapretero 150 mg Injection

Fosapretero 150 mg Injection

Fosapretero 150 mg Injection

*To be consumed as directed by physician.

Therapies:

Supportive

Composition:

Fosaprepitant (150 mg)

About Fosapretero 150 mg Injection

Fosapretero 150 mg Injection is a prescription antiemetic medication formulated with Fosaprepitant (150 mg). It is widely used in oncology care to help prevent nausea and vomiting associated with chemotherapy. It belongs to the class of medicines known as Neurokinin-1 receptor antagonists, which act on the brain’s vomiting centre to control nausea and vomiting.

Fosapretero 150 mg Injection

*To be consumed as directed by physician.


Usage Instructions

  • Fosapretero 150 mg injection should be administered only under the supervision of a qualified healthcare professional in a hospital.
  • It is usually given through an intravenous (IV) infusion before chemotherapy sessions to help prevent nausea and vomiting.
  • The dosage and duration are evaluated by the doctor based on the patient’s medical condition and treatment.
  • Patients are advised to stay well-hydrated and inform their healthcare provider about any allergies, ongoing medications, or unusual symptoms experienced during or after the infusion.

Benefits and Use

  • Fosapretero 150 mg injection is mainly used to prevent nausea and vomiting caused by cancer chemotherapy.
  • It works by blocking certain chemicals in the brain that trigger these symptoms, helping patients feel more comfortable during treatment.
  • It reduces chemotherapy-related discomfort and supports better nutrition, hydration, and overall well-being.
  • The injection is commonly suggested as part of an antiemetic treatment plan to improve the patient’s quality of life during cancer care.

Safety Information

  • Pregnancy
    • Use during pregnancy only if directed by a doctor after evaluating the potential benefits and risks.
  • Alcohol
    • Avoid alcohol consumption during treatment, as it may increase the chances of dizziness or discomfort.
  • Breastfeeding
    • Breastfeeding mothers should consult their doctor before receiving this injection, as safety information is limited.
  • Driving
    • This injection may cause tiredness or dizziness in some patients, so avoid driving or operating machinery if affected.
  • Kidney
    • Fosapretero 150 Mg Injection should be used cautiously in patients with kidney problems and under medical supervision.
  • Liver
    • Patients with liver disorders should inform their doctor before treatment, as dose adjustments may sometimes be required.

Ingredients

Fosaprepitant (150 mg)

How to Use

  • Fosapretero 150 mg injection is typically administered through IV only under the supervision of your physician in a clinical setting.
  • Do not self-administer this injection.

Storage Information

Store the injection between 2°C and 8°C